Glycopyrrolate Tablets — Class III drug recall D-164-2013
Terminated recall by West-ward Pharmaceutical Corp., reported 2013-02-20, distributed in OH. Subpotent Drug
| Recall number | D-164-2013 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | West-ward Pharmaceutical Corp., Eatontown, NJ, United States |
| Recall initiated | 2013-01-07 |
| Classified | 2013-02-12 |
| Reported by FDA | 2013-02-20 |
| Terminated | 2014-05-16 |
| Distributed | OH |
| Quantity | 1,185 bottles |
| Reason classes | potency |
| NDC | 00143-1250-01 |
| Lot numbers | 69001A |
Product
Glycopyrrolate Tablets, USP, 1 mg, Rx Only, 100 tablets per bottle, Manufactured by: West-ward Pharmaceutical Corp., Eatontown, NJ, 07724, NDC 0143-1250-01.
Reason for recall
Subpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-164-2013. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.